Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice

who benefits?

A J A Keen, E Duncan, A McKillop-Smith, N D Evans, A E Gold

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P
Original languageEnglish
Pages (from-to)670-676
Number of pages6
JournalDiabetic Medicine
Volume29
Issue number5
Early online date16 Apr 2012
DOIs
Publication statusPublished - May 2012

Fingerprint

Eating
Diabetic Ketoacidosis
Type 1 Diabetes Mellitus
Hypoglycemia
Psychology

Keywords

  • education
  • patient education
  • Type 1 diabetes

Cite this

Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice : who benefits? / Keen, A J A; Duncan, E; McKillop-Smith, A; Evans, N D; Gold, A E.

In: Diabetic Medicine, Vol. 29, No. 5, 05.2012, p. 670-676.

Research output: Contribution to journalArticle

Keen, A J A ; Duncan, E ; McKillop-Smith, A ; Evans, N D ; Gold, A E. / Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice : who benefits?. In: Diabetic Medicine. 2012 ; Vol. 29, No. 5. pp. 670-676.
@article{075f4166fffb4f05b01e21a13e35a3f1,
title = "Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?",
abstract = "Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6{\%}) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P",
keywords = "education, patient education, Type 1 diabetes",
author = "Keen, {A J A} and E Duncan and A McKillop-Smith and Evans, {N D} and Gold, {A E}",
note = "Journal compilation {\circledC} 2011 Diabetes UK.",
year = "2012",
month = "5",
doi = "10.1111/j.1464-5491.2011.03479.x",
language = "English",
volume = "29",
pages = "670--676",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley",
number = "5",

}

TY - JOUR

T1 - Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice

T2 - who benefits?

AU - Keen, A J A

AU - Duncan, E

AU - McKillop-Smith, A

AU - Evans, N D

AU - Gold, A E

N1 - Journal compilation © 2011 Diabetes UK.

PY - 2012/5

Y1 - 2012/5

N2 - Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P

AB - Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P

KW - education

KW - patient education

KW - Type 1 diabetes

U2 - 10.1111/j.1464-5491.2011.03479.x

DO - 10.1111/j.1464-5491.2011.03479.x

M3 - Article

VL - 29

SP - 670

EP - 676

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 5

ER -